Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs Amlodipine Strategy in Hypertension
NCT00304226Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2006
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of valsartan in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Blood pressure less than 140/90 mmHg at 14 weeks. Started Feb 2006; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00304226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304226.